21-hydroxylase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
Presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most potent risk factors in disease development. | |||
==Risk Factors== | ==Risk Factors== | ||
Presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most potent risk factors in disease development. | |||
==Risk Factors== | ==Risk Factors== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 13:52, 21 September 2015
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency risk factors |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most potent risk factors in disease development.
Risk Factors
Presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most potent risk factors in disease development.